SEC Form 4 · accession 0001209191-15-066127
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
L Patrick Gage
Director
Period of report
Aug 12, 2015
Accepted (ET)
Aug 14, 2015 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 12, 2015 | M | 15,000 | $7.07 | A | 20,000 | D | |
| Common Stock | Aug 12, 2015 | S | 15,000 | $45.00 | D | 5,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non Qualified Stock Option (Right to Buy)F1 | $7.07 | Aug 12, 2015 | M | 15,000 | D | — | Mar 24, 2023 | Common Stock | 15,000 | 5,000 | D |
Explanation of responses
- F1Vests in equal quarterly installments over a three-year period measured from the date of grant.